Shares of GSK PLC GSK advanced 1.98% to £13.68 Tuesday, on what proved to be an all-around positive trading session for the ...

Berenberg lowered the firm’s price target on GSK (GSK) to 1,600 GBp from 1,820 GBp and keeps a Buy rating on the shares.Don't Miss our Black ...

This writer takes a look at a beaten down FTSE 100 stock that has been sliding lower. Has it reached his Buy zone yet or is ...

Rising disposable income and improved healthcare infrastructure have enabled better access to cancer supportive care drugs, driving market growth. For instance, government initiatives in countries ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

Shares of GSK PLC GSK inched down 0.41% to £13.35 Friday, on what proved to be an all-around positive trading session for the ...

The global flu treatment market size was US$ 1037.5 million in 2021 and is forecast to reach US$ 1651.2 million by 2030, registering a compound annual growth rate (CAGR) of 5.2% during the forecast ...

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Pitcairn Co. cut its holdings in GSK plc (NYSE:GSK – Free Report) by 14.1% during the 3rd quarter, according to its most ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

Shares of GSK plc (NYSE:GSK – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the stock, Marketbeat.com reports. Seven ...